Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer

BACKGROUND: Mammary cancer has a high incidence in canines and is an excellent model of spontaneous carcinogenesis. Molecular iodine (I(2)) exerts antineoplastic effects on different cancer cells activating re-differentiation pathways. In co-administration with anthracyclines, I(2) impairs chemoresi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zambrano-Estrada, Xóchitl, Landaverde-Quiroz, Brianda, Dueñas-Bocanegra, Andrés A., De Paz-Campos, Marco A., Hernández-Alberto, Gerardo, Solorio-Perusquia, Benjamín, Trejo-Mandujano, Manuel, Pérez-Guerrero, Laura, Delgado-González, Evangelina, Anguiano, Brenda, Aceves, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848438/
https://www.ncbi.nlm.nih.gov/pubmed/29530037
http://dx.doi.org/10.1186/s12917-018-1411-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848438/
https://www.ncbi.nlm.nih.gov/pubmed/29530037
http://dx.doi.org/10.1186/s12917-018-1411-6

Ejemplares similares